Literature DB >> 26957479

The health-related quality of life journey of gynecologic oncology surgical patients: Implications for the incorporation of patient-reported outcomes into surgical quality metrics.

Kemi M Doll1, Emma L Barber2, Jeannette T Bensen3, Anna C Snavely4, Paola A Gehrig2.   

Abstract

OBJECTIVE: To report the changes in patient-reported quality of life for women undergoing gynecologic oncology surgeries.
METHODS: In a prospective cohort study from 10/2013-10/2014, women were enrolled pre-operatively and completed comprehensive interviews at baseline, 1, 3, and 6months post-operatively. Measures included the disease-specific Functional Assessment of Cancer Therapy-General (FACT-GP), general Patient Reported Outcome Measure Information System (PROMIS) global health and validated measures of anxiety and depression. Bivariate statistics were used to analyze demographic groups and changes in mean scores over time.
RESULTS: Of 231 patients completing baseline interviews, 185 (80%) completed 1-month, 170 (74%) 3-month, and 174 (75%) 6-month interviews. Minimally invasive (n=115, 63%) and laparotomy (n=60, 32%) procedures were performed. Functional wellbeing (20 → 17.6, p<0.0001) decreased at 1-month, and recovered by 3 and 6months. Emotional wellbeing increased (16.3 → 20.1, p<0.0001) and anxiety decreased (54.2 → 49.0, p<0.0001) at 1-month, and were stable at 3 and 6months. Physical wellbeing scales were not sensitive to surgery. These patterns were consistent across procedure type, cancer diagnosis, and adjuvant therapy administration. In an exploratory analysis of the interaction of QOL and quality, patients with increased postoperative healthcare resource use were noted to have higher baseline levels of anxiety.
CONCLUSIONS: For women undergoing gynecologic oncology procedures, temporary declines in functional wellbeing are balanced by improvements in emotional wellbeing and decreased anxiety symptoms after surgery. Not all commonly used QOL surveys are sensitive to changes during the perioperative period and may not be suitable for use in surgical quality metrics.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26957479      PMCID: PMC4978531          DOI: 10.1016/j.ygyno.2016.03.003

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  21 in total

1.  A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Karen M Gil; Heidi E Gibbons; Bradley J Monk; Peter G Rose; Deborah K Armstrong; David Cella; Lari Wenzel
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.

Authors:  Ignace Vergote; Claes G Tropé; Frédéric Amant; Gunnar B Kristensen; Tom Ehlen; Nick Johnson; René H M Verheijen; Maria E L van der Burg; Angel J Lacave; Pierluigi Benedetti Panici; Gemma G Kenter; Antonio Casado; Cesar Mendiola; Corneel Coens; Leen Verleye; Gavin C E Stuart; Sergio Pecorelli; Nick S Reed
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

4.  Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04.

Authors:  Marcia M Russell; Patricia A Ganz; Samia Lopa; Greg Yothers; Clifford Y Ko; Amit Arora; James N Atkins; Nathan Bahary; Gamini S Soori; John M Robertson; Janice Eakle; Benjamin T Marchello; Timothy F Wozniak; Robert W Beart; Norman Wolmark
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

5.  PROMIS fatigue, pain intensity, pain interference, pain behavior, physical function, depression, anxiety, and anger scales demonstrate ecological validity.

Authors:  Arthur A Stone; Joan E Broderick; Doerte U Junghaenel; Stefan Schneider; Joseph E Schwartz
Journal:  J Clin Epidemiol       Date:  2015-11-25       Impact factor: 6.437

6.  The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it.

Authors:  Tenbroeck G Smith; Kathleen M Castro; Alyssa N Troeschel; Neeraj K Arora; Joseph Lipscomb; Shelton M Jones; Katherine A Treiman; Connie Hobbs; Ryan M McCabe; Steven B Clauser
Journal:  Cancer       Date:  2015-11-30       Impact factor: 6.860

7.  Using patient-reported outcome measures as quality indicators in routine cancer care.

Authors:  Angela M Stover; Ethan M Basch
Journal:  Cancer       Date:  2015-11-30       Impact factor: 6.860

8.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

9.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Authors:  Ethan Basch; Allison M Deal; Mark G Kris; Howard I Scher; Clifford A Hudis; Paul Sabbatini; Lauren Rogak; Antonia V Bennett; Amylou C Dueck; Thomas M Atkinson; Joanne F Chou; Dorothy Dulko; Laura Sit; Allison Barz; Paul Novotny; Michael Fruscione; Jeff A Sloan; Deborah Schrag
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

Review 10.  Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates.

Authors:  Sam Watts; Philip Prescott; Jessica Mason; Natalie McLeod; George Lewith
Journal:  BMJ Open       Date:  2015-11-30       Impact factor: 2.692

View more
  7 in total

1.  Adaptation of the Possibilities for Activity Scale for women encountering cancer (PActS-W).

Authors:  Mackenzi Pergolotti; Kemi M Doll; Emily O Fawaz; Bryce B Reeve
Journal:  Aust Occup Ther J       Date:  2018-09-04       Impact factor: 1.856

2.  Roles of preoperative anxiety and depression in the outcomes of microvascular decompression in hemifacial spasm for adolescent patients.

Authors:  Fan Wu; Pingcun Wei; Gang Wang; Changsong Wu; Yunlong Hu; Jinwang Hu
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

3.  The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship.

Authors:  Nora B Henrikson; Melissa L Anderson; John Dickerson; John J Ewing; Robin Garcia; Erin Keast; Deborah A King; Cara Lewis; Blake Locher; Carmit McMullen; Consuelo M Norris; Amanda F Petrik; Arvind Ramaprasan; Jennifer S Rivelli; Jennifer L Schneider; Lisa Shulman; Leah Tuzzio; Matthew P Banegas
Journal:  Trials       Date:  2022-05-13       Impact factor: 2.728

Review 4.  Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review.

Authors:  Thi Xuan Mai Tran; Jungeun Park; Joonki Lee; Yuh-Seog Jung; Yoonjung Chang; Hyunsoon Cho
Journal:  Support Care Cancer       Date:  2020-10-15       Impact factor: 3.603

5.  Who presents satisfied? Non-modifiable factors associated with patient satisfaction among gynecologic oncology clinic patients.

Authors:  Emma L Barber; Jeannette T Bensen; Anna C Snavely; Paola A Gehrig; Kemi M Doll
Journal:  Gynecol Oncol       Date:  2016-06-11       Impact factor: 5.482

Review 6.  Psychological problems among cancer patients in relation to healthcare and societal costs: A systematic review.

Authors:  Florie E Van Beek; Lonneke M A Wijnhoven; Karen Holtmaat; José A E Custers; Judith B Prins; Irma M Verdonck-de Leeuw; Femke Jansen
Journal:  Psychooncology       Date:  2021-07-06       Impact factor: 3.955

7.  The utility of patient reported data in a gynecologic oncology clinic.

Authors:  D Barnes; R Rivera; S Gibson; C Craig; J Cragun; B Monk; D Chase
Journal:  Gynecol Oncol Res Pract       Date:  2018-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.